LRRC75A and breast cancer: Taken together, some immunocytes, including basophil, natural killer T cell, B cell, CD8+ T cell, eosinophil or mesenchymal stem cell, might be involved in interaction with LRRC75A-AS1-mediated inflammation in breast cancer.